Newsroom
Sorted by: Latest
-
Samenvatting: Corpay Cross-Border uitgeroepen tot Official Global FX Partner van Fever
TORONTO--(BUSINESS WIRE)--Corpay, Inc.*, (NYSE: CPAY) een wereldleider in bedrijfsbetalingen, maakte vandaag bekend dat zijn Cross-Border-activiteit een akkoord heeft gesloten met Fever, een toonaangevend internationaal platform voor het ontdekken en boeken van tickets voor live entertainment dat gespecialiseerd is in onderdompelende ervaringen, concerten bij kaarlicht en interactieve pop-up evenementen. In het kader van dit akkoord wordt Corpay exclusieve en Official Global Foreign Exchange (F...
-
Riassunto: Corpay Cross-Border nominata il partner FX ufficiale globale di Fever
TORONTO--(BUSINESS WIRE)--Corpay, Inc.*, (NYSE: CPAY) un leader globale nei pagamenti aziendali, oggi ha reso noto che la sua attività Cross-Border ha stretto un accordo con Fever, una piattaforma leader globale nella scoperta e vendita di biglietti di spettacoli dal vivo specializzata in esperienze immersive, concerti a lume di candela ed eventi pop interattivi. Grazie all'accordo, Corpay diventa il partner ufficiale ed esclusivo globale di Fever per il cambio valute (FX). Grazie alla collabor...
-
Archer® comprova que IA desenvolvida para fins específicos supera LLMs de uso geral na gestão de mudanças regulatórias: 95% de precisão verificada, 80 vezes mais rápida e custo 92% menor
OVERLAND PARK, Kansas--(BUSINESS WIRE)--Para empresas que implementam IA em processos de conformidade, uma data incorreta significa um prazo perdido. A falha mais perigosa é uma resposta errada que o modelo oferece com um alto grau de confiança; uma resposta que se integra silenciosamente em um cronograma de conformidade e só é descoberta depois que o prazo expirou. A Archer® divulgou hoje os resultados demonstrando que uma IA desenvolvida para fins específicos supera um modelo de linguagem ext...
-
NorthWestern Energy to Host Second Quarter 2026 Financial Results Webinar
BUTTE, Mont. & SIOUX FALLS, S.D.--(BUSINESS WIRE)--NorthWestern Energy Group, Inc. d/b/a NorthWestern Energy (Nasdaq: NWE) today announced that it will host an investor webinar on Thursday, July 30, 2026, at 3:30 p.m. Eastern to review its financial results for the quarter ending June 30, 2026. The Company also plans to issue a news release detailing its financial results the evening of Wednesday, July 29, 2026. To register for the webinar, please visit https://northwesternenergy.com/earnings-r...
-
Corpay Cross-Border nommée partenaire officiel mondial de Fever pour le marché des changes
TORONTO--(BUSINESS WIRE)--Corpay, Inc.* (NYSE : CPAY), leader mondial des paiements d’entreprise, a annoncé aujourd’hui que sa division Cross-Border a conclu un accord avec Fever, une plateforme mondiale de premier plan dédiée à la découverte de spectacles live et à la billetterie. Cette plateforme est spécialisée dans les expériences immersives, les concerts aux chandelles et les événements interactifs éphémères. Conformément à cet accord, Corpay devient le partenaire officiel exclusif de Feve...
-
VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs
PHOENIX--(BUSINESS WIRE)--VIVAZEN®, the nation’s leading botanical wellness company, welcomes the Drug Enforcement Administration’s (DEA) decision to classify 7-hydroxymitragynine (7-OH) and three related drugs as Schedule I drug. 7-OH is a dangerous synthetic, lab-made drug that HHS and FDA have described as harmful and addictive. 7-OH has raised serious concerns for public health and consumer safety. This move critically distinguishes these harmful synthetic drugs and the natural botanical kr...
-
Kilroy Realty Corporation Announces Dates for Second Quarter 2026 Earnings Release and Conference Call
LOS ANGELES--(BUSINESS WIRE)--Kilroy Realty Corporation (NYSE: KRC) ("Kilroy" or the “Company”) announced today it will release second quarter 2026 financial results after the market closes on Monday, July 27, 2026. Kilroy will hold a conference call to discuss the results at 10:00 a.m. PT / 1:00 p.m. ET on Tuesday, July 28, 2026. To participate and obtain conference call dial-in details, register by using the following link: https://events.q4inc.com/analyst/213776497?pwd=miK0Lhqd. This call wi...
-
The Radoff-Jumana Group Calls for Joanna Barsh to Immediately Resign from Genesco Inc.’s Board of Directors Based on False and Misleading Biographical Information
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff, Jumana Capital Investments LLC and Christopher R. Martin (collectively, the “Radoff-Jumana Group” or “we”), who collectively own approximately 9.1% of the outstanding shares of Genesco Inc. (NYSE: GCO) (“Genesco” or the “Company”), today issued the following statement: “The Company’s proxy statement touts Joanna Barsh’s supposed credentials to serve on Genesco’s Board of Directors. It claims, inaccurately, that she has ‘Public Company Leadership (CEO...
-
AIG to Report Second Quarter 2026 Financial Results on August 6, 2026, and Host Conference Call on August 7, 2026
NEW YORK--(BUSINESS WIRE)--American International Group, Inc. (NYSE: AIG) will report financial results for the second quarter ended June 30, 2026, after the market closes on Thursday, August 6, 2026. AIG’s press release and financial supplement will be available in the Investors section of AIG’s website at https://www.aig.com. AIG will also host a conference call on Friday, August 7, 2026, at 8:30 a.m. ET to review these results. The live, listen-only webcast is open to the public and can be a...
-
Caidya宣布與Simbec-Orion達成策略性整合,串接早期科學洞察與全球臨床執行
北卡羅來納州羅利市與倫敦--(BUSINESS WIRE)--(美國商業資訊)-- Caidya今日宣布與Simbec-Orion達成策略性整合,旨在彌合早期科學洞察與全球臨床執行之間的落差。Caidya與Simbec-Orion的整合打造出具差異化的專業臨床研究機構(CRO)平台,使各項計畫得以擴展規模,同時維持專注度、速度與責任機制。 此次策略性整合匯集互補優勢,為創新生物製藥公司打造更完整的研發合作夥伴。憑藉在歐洲、美洲、亞太及中國已建立的營運據點,整合後的組織能在最關鍵的區域提供具實質意義的專業能力與執行能力。 Simbec-Orion具備早期臨床藥理能力,並在後期複雜的腫瘤與罕見疾病試驗方面擁有深厚的治療領域專業,協助申辦方在研發生命週期早期做出關鍵決策。雙方合併後,將強化支援複雜跨境專案的能力,並提供更完整的銜接路徑,從人體第一次試驗,涵蓋健康受試者與病患族群,一直到產品註冊階段。 其結果是更廣泛的能力、更深入的專業,以及更高的連續性,並以客戶對專業型臨床研究機構所期待的即時回應、責任機制與緊密協作方式交付。 憑藉在歐洲長期建立的營運基礎,以及近五十年支持創新生物製藥公司的...